Global Plasma Therapy Market, By Type (Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others), End User (Hospitals and Clinics, Research Institutions), and Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Plasma Therapy Market
The plasma therapy market is expected to witness market growth at a rate of 13.66% in the forecast period of 2021 to 2028. Data Bridge Market Research report on plasma therapy market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the incidences of sports injuries is escalating the growth of plasma therapy market.
Blood is known to be made up of white blood cells (WBCs), red blood cells (RBCs), plasma and platelets. In the plasma therapy, the immunity of a healthy recovered individual can be transported to the patient with the assistance of plasma, because it comprises of high concentration of antibodies. The plasma therapy has been utilized for a long time, mainly in the dentistry, dermatology and orthopedics. Plasma treatment is usually used in the wound healing, androgenetic alopecia and facial restoration.
Major factors that are expected to boost the growth of the plasma therapy market in the forecast period are the rise in the number of androgenic alopecia patients around the world. Furthermore, the increase in the utilization of platelet-rich plasma in the several therapeutic areas is further anticipated to propel the growth of the plasma therapy market. Also, the rise in the incidence of arthritis is further estimated to cushion the growth of the plasma therapy market. On the other hand, the dearth of reimbursement policies and the different costs of plasma therapy is further projected to impede the growth of the plasma therapy market in the timeline period.
In addition, the rise in the number of patients that are suffering from orthopedic disorders and androgenic alopecia will further provide potential opportunities for the growth of the plasma therapy market in the coming years. However, the limited utilization of PRP in the patients suffering from diabetes and kidney ailments might further create challenges for the growth of the plasma therapy market in the near future.
This plasma therapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on plasma therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Plasma Therapy Market Scope and Market Size
The plasma therapy market is segmented on the basis of type, source, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the plasma therapy market is segmented into pure PRP, leucocyte-rich PRP, pure platelet-rich fibrin, leukocyte-rich fibrin.
- On the basis of source, the plasma therapy market is segmented into autologous, allogenic.
- On the basis of application, the plasma therapy market is segmented into orthopedics, dermatology, dental, cardiac muscle injury, nerve injury, others. Orthopedics is further sub segmented into arthritis, chronic tendinitis and bone repair and regeneration. Dermatology is further sub segmented into androgenic alopecia and plastic surgery.
- On the basis of end user, the plasma therapy market is segmented into hospitals and clinics, research institutions.
Plasma Therapy Market Country Level Analysis
The plasma therapy market is analysed and market size insights and trends are provided by country, type, source, application and end user as referenced above.
The countries covered in the plasma therapy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the plasma therapy market due to the rise in the number of hospitals and clinics. Furthermore, the increase in the alertness levels amongst the blood donors and the existence of the advanced protein fractioning processes will further boost the growth of the plasma therapy market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the plasma therapy market due to the rise in the medical tourism and technological developments.
The country section of the plasma therapy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The plasma therapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for plasma therapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the plasma therapy market. The data is available for historic period 2010-2019.
Competitive Landscape and Plasma Therapy Market Share Analysis
The plasma therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to plasma therapy market.
The major players covered in the plasma therapy market report are Arthrex, Inc., Bio Products Laboratory Ltd., Takeda Pharmaceutical Company Limited., Biotest AG., Cambryn Biologics, China Biologic Products Holdings, Inc., CSL Limited, DePuy Synthes, Grifols, S.A., Kedrion S.p.A., Octapharma, Regen Lab SA, Stryker Corporation, Telecris Indústria e Comércio Ltda., Baxter, Japanese Red Cross Society, Sanquin Oy, LFB SA, TERUMO BCT, INC., and Chengdu Institute of Biology (CIB), among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-